Lexaria Bioscience (LEXX) Stock Chart & Stock Price History → Forget Nvidia, buy this A.I. Stock Now (From InvestorPlace) (Ad) Free LEXX Stock Alerts $2.34 +0.03 (+1.30%) (As of 04/17/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Lexaria Bioscience Stock Price Performance5 Day Performance+10.38%1 Month Performance-40.00%3 Month Performance+43.56%6 Month Performance+143.75%Year-To-Date Performance+87.20%1 Year Performance+7.83% Receive LEXX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Lexaria Bioscience and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlaceForget Nvidia, buy this A.I. Stock NowForget Nvidia, Microsoft or Google. Our tech expert and venture capitalist Luke Lango believes this is Elon Musk’s favorite A.I. stock. Why? Because this company is supplying Elon Musk with a key piece of advanced tech for his new A.I. venture.Click here to see the details. LEXX Stock Chart for Wednesday, April, 17, 2024 LEXX Chart by TradingView Lexaria Bioscience Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/17/2024$2.31$2.34+1.30%$2.73$2.25460,980 shs$30.15 million04/16/2024$1.99$2.31+16.08%$2.34$1.85295,779 shs$29.78 million04/15/2024$2.12$1.99-6.13%$2.14$1.91315,206 shs$25.65 million04/12/2024$2.51$2.12-15.54%$2.64$2.12455,728 shs$27.33 million04/11/2024$2.66$2.51-5.64%$2.72$2.50249,689 shs$31.07 million04/10/2024$2.70$2.66-1.48%$2.79$2.60143,381 shs$32.93 million Get the Latest News and Ratings for LEXX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lexaria Bioscience and its competitors with MarketBeat's FREE daily newsletter. 04/09/2024$2.96$2.70-8.78%$3.03$2.65246,698 shs$33.43 million04/08/2024$3.05$2.96-2.95%$3.18$2.93155,255 shs$36.64 million04/05/2024$3.19$3.05-4.39%$3.29$3.05124,644 shs$37.76 million04/04/2024$3.41$3.19-6.45%$3.48$3.17269,046 shs$39.49 million04/03/2024$3.47$3.41-1.73%$3.57$3.23245,726 shs$42.21 million04/02/2024$3.42$3.47+1.46%$3.50$3.32134,442 shs$42.96 million04/01/2024$3.63$3.42-5.79%$3.82$3.25159,197 shs$42.34 million03/29/2024$3.63$3.63$3.92$3.59168,460 shs$44.94 million03/28/2024$3.71$3.63-2.16%$3.92$3.59168,193 shs$44.93 million03/27/2024$3.79$3.71-2.11%$3.91$3.60232,650 shs$45.93 million03/26/2024$3.95$3.79-4.05%$3.95$3.75234,085 shs$46.92 million03/25/2024$3.47$3.95+13.83%$4.00$3.41604,742 shs$48.90 million03/22/2024$3.44$3.47+0.87%$3.55$3.30186,345 shs$42.96 million03/21/2024$3.70$3.44-7.03%$3.96$3.36844,669 shs$42.59 million03/20/2024$4.00$3.70-7.50%$4.22$3.61403,269 shs$45.81 million03/19/2024$3.40$4.00+17.65%$4.17$2.991.09 million shs$49.52 million03/18/2024$3.90$3.40-12.82%$3.89$3.15818,051 shs$42.09 million03/15/2024$3.85$3.90+1.30%$4.05$3.65464,304 shs$48.28 million03/14/2024$4.40$3.85-12.50%$4.49$3.75508,673 shs$47.66 million03/13/2024$4.18$4.40+5.26%$5.18$4.02996,390 shs$54.47 million03/12/2024$6.25$4.18-33.12%$6.45$3.363.63 million shs$51.75 million03/11/2024$5.50$6.25+13.64%$6.85$5.491.26 million shs$77.38 million03/08/2024$5.00$5.50+10.00%$6.01$5.051.53 million shs$57.42 million03/07/2024$4.48$5.00+11.61%$5.34$4.201.42 million shs$52.20 million03/06/2024$3.38$4.48+32.54%$4.50$3.451.36 million shs$46.77 million03/05/2024$3.00$3.38+12.67%$3.61$2.811.00 million shs$35.29 million03/04/2024$2.92$3.00+2.74%$3.25$2.75643,588 shs$31.31 million03/01/2024$3.45$2.92-15.36%$2.93$2.311.61 million shs$30.49 million02/29/2024$2.55$3.45+35.29%$3.45$2.651.02 million shs$36.00 million02/28/2024$2.40$2.55+6.25%$2.95$2.501.01 million shs$26.62 million02/27/2024$2.26$2.40+6.19%$2.75$2.26704,837 shs$25.06 million02/26/2024$2.21$2.26+2.26%$2.27$2.18137,988 shs$23.59 million02/23/2024$2.27$2.21-2.64%$2.25$2.0693,345 shs$23.07 million02/22/2024$2.25$2.27+0.89%$2.37$2.13290,370 shs$23.70 millionForget Nvidia, buy this A.I. Stock Now (Ad)Forget Nvidia, Microsoft or Google. Our tech expert and venture capitalist Luke Lango believes this is Elon Musk’s favorite A.I. stock. Why? Because this company is supplying Elon Musk with a key piece of advanced tech for his new A.I. venture.Click here to see the details.02/21/2024$2.32$2.25-3.02%$2.30$2.22103,198 shs$23.49 million02/20/2024$2.14$2.32+8.41%$2.35$2.14205,246 shs$24.22 million02/19/2024$2.14$2.14$2.41$2.10428,500 shs$22.33 million02/16/2024$2.36$2.14-9.32%$2.41$2.10423,054 shs$22.34 million02/15/2024$2.60$2.36-9.23%$2.65$2.25432,591 shs$24.63 million02/14/2024$2.46$2.60+5.69%$2.78$2.40315,657 shs$27.13 million02/13/2024$2.27$2.46+8.37%$2.58$2.25233,028 shs$25.68 million02/12/2024$2.30$2.27-1.30%$2.42$2.21199,083 shs$23.70 million02/09/2024$1.90$2.30+21.05%$2.52$1.88787,640 shs$24.01 million02/08/2024$1.98$1.90-4.04%$2.10$1.90138,091 shs$19.84 million02/07/2024$1.94$1.98+2.06%$2.09$1.90226,624 shs$20.67 million02/06/2024$1.71$1.94+13.45%$2.16$1.70549,437 shs$20.25 million02/05/2024$1.74$1.71-1.72%$2.21$1.65533,445 shs$17.85 million02/02/2024$1.57$1.74+10.83%$1.79$1.50237,606 shs$18.17 million02/01/2024$1.49$1.57+5.37%$1.58$1.4773,295 shs$16.39 million01/31/2024$1.48$1.49+0.68%$1.55$1.4354,177 shs$15.55 million01/30/2024$1.50$1.48-1.33%$1.63$1.4643,306 shs$15.45 million01/29/2024$1.42$1.50+5.63%$1.50$1.4241,863 shs$15.66 million01/26/2024$1.46$1.42-2.74%$1.50$1.3658,481 shs$14.83 million01/25/2024$1.57$1.46-7.01%$1.60$1.45100,905 shs$15.24 million01/24/2024$1.52$1.57+3.29%$1.61$1.51116,755 shs$16.39 million01/23/2024$1.53$1.52-0.33%$1.59$1.5098,368 shs$15.87 million01/22/2024$1.47$1.53+3.74%$1.53$1.4535,951 shs$15.92 million01/19/2024$1.62$1.47-9.26%$1.58$1.43208,393 shs$15.35 million01/18/2024$1.63$1.62-0.61%$1.67$1.50240,233 shs$16.91 million01/17/2024$1.55$1.63+5.16%$1.68$1.54226,324 shs$17.02 million01/16/2024$1.51$1.55+2.65%$1.64$1.47272,167 shs$15.93 million Related Companies: APRE Stock Chart ACST Stock Chart SPRB Stock Chart APM Stock Chart LPCN Stock Chart IPA Stock Chart FBIO Stock Chart ACXP Stock Chart THTX Stock Chart EYEN Stock Chart Receive LEXX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Lexaria Bioscience and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LEXX) was last updated on 4/17/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsOptions trading has suddenly become more reliable.Eagle PublishingTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsThe #1 Crypto for 2024InvestorPlaceThe Greatest Bull Market in Crypto History…Weiss RatingsA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lexaria Bioscience Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.